Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,287,303 papers from all fields of science
Search
Sign In
Create Free Account
MVPP protocol
Known as:
MVPP
, Mechlorethamine/Prednisone/Procarbazine/Vinblastine
, NM/PCB/PRED/VBL
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
Broader (5)
Antineoplastic Combined Chemotherapy Protocols
Mechlorethamine
Procarbazine
Vinblastine
Expand
Mechlorethamine hydrochloride
Prednisone
Procarbazine Hydrochloride
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Establishment of a novel anabolism-based addiction system with an artificially introduced mevalonate pathway: complete stabilization of plasmids as universal application in white biotechnology.
J. Kroll
,
A. Steinle
,
R. Reichelt
,
Christian Ewering
,
A. Steinbüchel
Metabolic Engineering
2009
Corpus ID: 29326331
Review
1998
Review
1998
Socio-medical situation for long-term survivors of Hodgkin's disease: a survey of 459 patients treated at one institution.
A. F. Abrahamsen
,
J. H. Loge
,
E. Hannisdal
,
H. Holte
,
S. Kvaløy
European Journal of Cancer
1998
Corpus ID: 19564368
1987
1987
THE PITUITARY‐LEYDIG CELL AXIS IN MEN WITH SEVERE DAMAGE TO THE GERMINAL EPITHELIUM
A. Tsatsoulis
,
E. Whitehead
,
J. John
,
S. Shalet
,
W. Robertson
Clinical Endocrinology
1987
Corpus ID: 34642553
Eighteen men (mean age 27, range 18‐30 years) treated for Hodgkin's disease with 6‐8 courses of MVPP (Mustine, Vinblastine…
Expand
Review
1987
Review
1987
Angio-immunoblastic lymphadenopathy: a clinical, immunological and molecular study.
T. Ganesan
,
H. Dhaliwal
,
M. Dorreen
,
A. Stansfeld
,
J. Habeshaw
,
T. Lister
British Journal of Cancer
1987
Corpus ID: 6734819
Twenty four patients with angio-immunoblastic lymphadenopathy (AILD) presenting between 1974 and 1985 have been reviewed…
Expand
1986
1986
Factors affecting remission and survival in patients with advanced hodgkin's disease treated with MVPP
J. Wagstaff
,
W. Steward
,
+6 authors
D. Crowther
Hematological Oncology
1986
Corpus ID: 31103619
One hundred and fourteen patients with clinical or pathological stages IIIB and IV Hodgkin's disease have been treated with MVPP…
Expand
Highly Cited
1984
Highly Cited
1984
A randomized study comparing chemotherapy alone with chemotherapy followed by radiotherapy in patients with pathologically staged IIIA Hodgkin's disease.
D. Crowther
,
J. Wagstaff
,
+6 authors
J. Howard Scarffe
Journal of Clinical Oncology
1984
Corpus ID: 36804699
This paper reports the five-year follow-up (range, 1-8 years) of 56 patients with pathologic stage IIIA Hodgkin's disease…
Expand
1983
1983
The effects of conventionally fractionated, extended portal radiotherapy on the human peripheral blood count.
P. N. Plowman
International Journal of Radiation Oncology…
1983
Corpus ID: 19772789
Highly Cited
1982
Highly Cited
1982
The effects of Hodgkin's disease and combination chemotherapy on gonadal function in the adult male
E. Whitehead
,
S. Shalet
,
G. Blackledge
,
I. Todd
,
D. Crowther
,
C. Beardwell
Cancer
1982
Corpus ID: 33064031
The effects of Hodgkin's disease and quadruple chemotherapy on gonadal function have been investigated in 93 male patients with…
Expand
Highly Cited
1980
Highly Cited
1980
Measurement of drug dosage intensity in MVPP therapy in Hodgkin's disease.
J. Green
,
A. Dawson
,
L. Fell
,
S. Murray
British Journal of Clinical Pharmacology
1980
Corpus ID: 20941367
The dose of combination chemotherapy in Hodgkin's disease is commonly calculated from a formula based on the body surface area. A…
Expand
Highly Cited
1978
Highly Cited
1978
MVPP chemotherapy regimen for advanced Hodgkin's disease
S. Sutcliffe
,
P. Wrigley
,
+5 authors
J. Malpas
British medical journal
1978
Corpus ID: 25738092
During January 1968 to December 1972, 133 patients with advanced Hodgkin's disease (HD) were admitted to hospital for combination…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE